Showing results (111-120 of 290) with videos related to
Sort By:
Pageof 29
Cancer|October 7, 2005
Randomized phase II study of weekly docetaxel plus trastuzumab versus weekly paclitaxel plus trastuzumab in patients with previously untreated advanced nonsmall cell lung carcinomaLee M Krug, Vincent A Miller, Jyoti Patel, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 27, 2005
TRIBUTE: a phase III trial of erlotinib hydrochloride (OSI-774) combined with carboplatin and paclitaxel chemotherapy in advanced non-small-cell lung cancerRoy S Herbst, Diane Prager, Robert Hermann, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 21, 2011
Phase I/II trial of cetuximab and erlotinib in patients with lung adenocarcinoma and acquired resistance to erlotinibYelena Y Janjigian, Christopher G Azzoli, Lee M Krug, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 7, 2006
Novel D761Y and common secondary T790M mutations in epidermal growth factor receptor-mutant lung adenocarcinomas with acquired resistance to kinase inhibitorsMarissa N Balak, Yixuan Gong, Gregory J Riely, et al.Cancer Research|November 13, 2013
D538G mutation in estrogen receptor-α: A novel mechanism for acquired endocrine resistance in breast cancerKeren Merenbakh-Lamin, Noa Ben-Baruch, Adva Yeheskel, et al.Cancer Discovery|July 31, 2014
Dual inhibition of EGFR with afatinib and cetuximab in kinase inhibitor-resistant EGFR-mutant lung cancer with and without T790M mutationsYelena Y Janjigian, Egbert F Smit, Harry J M Groen, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2006
Use of cigarette-smoking history to estimate the likelihood of mutations in epidermal growth factor receptor gene exons 19 and 21 in lung adenocarcinomasDuyKhanh Pham, Mark G Kris, Gregory J Riely, et al.Breast Cancer Research and Treatment|January 15, 2016
Clinically advanced and metastatic pure mucinous carcinoma of the breast: a comprehensive genomic profiling studyJeffrey S Ross, Laurie M Gay, Sahar Nozad, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2004
Vaccination of patients with small-cell lung cancer with synthetic fucosyl GM-1 conjugated to keyhole limpet hemocyaninLee M Krug, Govind Ragupathi, Chandra Hood, et al.European Journal of Cancer (Oxford, England : 1990)|March 24, 2015
Comparative analysis of primary tumour and matched metastases in colorectal cancer patients: evaluation of concordance between genomic and transcriptional profilesStéphane Vignot, Céline Lefebvre, Garrett M Frampton, et al.Pageof 29